Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Anna Drewek"'
Autor:
Jan Klohs, Igna Wojtyna Politano, Andreas Deistung, Joanes Grandjean, Anna Drewek, Marco Dominietto, Ruth Keist, Ferdinand Schweser, Jürgen R Reichenbach, Roger M Nitsch, Irene Knuesel, Markus Rudin
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e66097 (2013)
Magnetic resonance imaging (MRI) can be used to monitor pathological changes in Alzheimer's disease (AD). The objective of this longitudinal study was to assess the effects of progressive amyloid-related pathology on multiple MRI parameters in transg
Externí odkaz:
https://doaj.org/article/963e29b8b0b04cb3b12f44ceb5fa1a84
Publikováno v:
Journal of Ambient Intelligence and Humanized Computing. 12:497-514
In recent years, advancements in the field of the artificial intelligence (AI) gained a huge momentum due to the worldwide appliance of this technology by the industry. One of the crucial areas of AI are neural networks (NN), which enable commercial
Autor:
Peter Bühlmann, Bernd Rinn, Vincent Rouilly, Shyan Huey Low, Christoph Dehio, Matthias C. Truttmann, Pauli Rämö, Niko Beerenwinkel, Wolf-Dietrich Hardt, Gabriel Studer, Mario Emmenlauer, Alain Casanova, Christian von Mering, Jason Mercer, Eva Pujadas, Juliane Siebourg-Polster, Cécile Arrieumerlou, Houchaima Ben-Tekaya, Michael Podvinec, Javier Pizarro-Cerdá, Artur Yakimovich, Andreas Kaufmann, Michael Stebler, Raquel Conde-Álvarez, Bettina Cardel, Simone Eicher, Fabian Schmich, Ari Helenius, Anna Drewek, Peter Z. Kunszt, Christoph Kasper, Lucas Pelkmans, Simone Muntwiler, Ewa Szczurek, Gabor Csucs, Pascale Cossart, Andreas Kühbacher, Daria Mudrak, Berend Snijder, Saskia Kreibich, Urs F. Greber, Andreas Vonderheit
Publikováno v:
BMC genomics
BMC Genomics, 15
BMC Genomics (15), article 1162 (18 p.). (2014)
BMC Genomics
BMC Genomics, 2014, 15, article 1162 (18 p.). ⟨10.1186/1471-2164/15/1162⟩
BMC Genomics, BioMed Central, 2014, 15, article 1162 (18 p.). ⟨10.1186/1471-2164/15/1162⟩
BMC Genomics, 15
BMC Genomics (15), article 1162 (18 p.). (2014)
BMC Genomics
BMC Genomics, 2014, 15, article 1162 (18 p.). ⟨10.1186/1471-2164/15/1162⟩
BMC Genomics, BioMed Central, 2014, 15, article 1162 (18 p.). ⟨10.1186/1471-2164/15/1162⟩
Background Large-scale RNAi screening has become an important technology for identifying genes involved in biological processes of interest. However, the quality of large-scale RNAi screening is often deteriorated by off-targets effects. In order to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9539cd22b9c8444577acf818184f83f5
https://edoc.unibas.ch/35463/
https://edoc.unibas.ch/35463/
Autor:
Ruth Keist, Andreas Deistung, Marco Dominietto, Ferdinand Schweser, Jan Klohs, Igna Wojtyna Politano, Anna Drewek, Markus Rudin, Irene Knuesel, Jürgen R. Reichenbach, Roger M. Nitsch, Joanes Grandjean
Publikováno v:
PLoS ONE, 8 (6)
PLOS ONE
PLoS ONE, Vol 8, Iss 6, p e66097 (2013)
PLoS ONE
PloS one
PLOS ONE
PLoS ONE, Vol 8, Iss 6, p e66097 (2013)
PLoS ONE
PloS one
Magnetic resonance imaging (MRI) can be used to monitor pathological changes in Alzheimer's disease (AD). The objective of this longitudinal study was to assess the effects of progressive amyloid-related pathology on multiple MRI parameters in transg